ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Xenotransplantation"

  • 2016 American Transplant Congress

    aPC Pretreatment of hEPCR-Expressing PAECs Attenuates Endothelial Cell Damage and Thrombosis.

    C. Laird,1 B. French,1 D. Harris,1 X. Chang,1 D. Ayares,2 R. Pierson,1 A. Azimzadeh.1

    1Cardiac Surgery, University of Maryland School of Medicine, Baltimore, MD; 2Revivicor, Inc, Blacksburg, VA.

    IntroductionActivated Protein C (aPC), acting primarily through the human endothelial protein C receptor (hEPCR), mediates anti-thrombotic and anti-inflammatory cytoprotective effects in humans. We hypothesized that…
  • 2016 American Transplant Congress

    In Vivo and In Vitro Characterization of 1.5 mm Ba2+-Alginate Macro-Encapsulated Cynomolgus Monkey Islets.

    M. Bochenek,1 J. McGarrigle,1 J. Mendoza-Elias,1 E. Marchese,1 M. Nourmohammadzadeh,1 Y. Wang,1 A. Khan,1 M. Omami,1 C.-C. Yeh,1 I. Lacik,2 B. Strand,3 J. Oberholzer.1

    1Transplant Surgery, University of Iliinois at Chicago, Chicago, IL; 2Biomaterials Research, Polymer Institute of the Slovak Academy of Sciences, Bratislava, Slovakia (Slovak Republic); 3Biotechnology, Norwegian University of Science and Technology, Trondheim, Norway.

    Introduction:Micro-encapsulation of islets for the treatment of Type I diabetes has shown limited efficacy in small-scale clinical trials. The lack of success may be related…
  • 2016 American Transplant Congress

    Establishment of SCID Pigs Cell Lines to Prevent Immunodeficiency Using RGEN System.

    D.-H. Kim,1 J.-S. Ahn,1 S. Hwang,2 J.-W. Lee.1

    1Functional Genomics Reaserch Center, KRIBB, Daejeon, Korea; 2Animal Biotechnology Division, RDA, Wanju-gun, Jeollabuk-do, Korea.

    Severe immune disorder is the biggest problem in xenotransplantation. To overcome the the problem, producing severe combined immune deficiency (SCID) pigs which lack T cell…
  • 2016 American Transplant Congress

    The Impact of Sequential Gene Modifications on Cardiac Xenograft Survival.

    K. Horvath,1 A. Singh,1 J. Chan,1 M. Thomas,2 B. Lewis,2 D. Ayares,3 P. Corcoran,1 M. Mohiuddin.1

    1CSRP, NHLBI/NIH, Bethesda, MD; 2DVR / ORS, NIH, Bethesda, MD; 3Revivicor, Inc, Blacksburg, VA.

    Introduction: One of the major advances in xenotransplantation is the ability to modify donor pig genetics. Using rapidly evolving techniques of pig cloning and gene…
  • 2016 American Transplant Congress

    Inclusion of Human Tissue Factor Pathway Inhibitor or Thrombomodulin Transgenes Attenuates Critical Consumptive Thrombocytopenia in Cardiac Xenotransplantation.

    J. Chan,1 A. Singh,1 P. Corcoran,1 M. Thomas III,2 B. Lewis,2 D. Ayares,3 K. Horvath,1 M. Mohiuddin.1

    1Cardiothoracic Surgery Research Program/National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD; 2Division of Veterinary Resources, National Institutes of Health, Bethesda, MD; 3Revivicor Inc., Blacksburg, VA.

    ObjectiveA major obstacle in the success of cardiac xenotransplantation has been the development of significant consumptive thrombocytopenia, frequently limiting recipient survival. Advances in genetic engineering…
  • 2016 American Transplant Congress

    Costimulation Blockade by Anti CD40 Antibody Prevents Humoral and Cellular Rejection of Heterotopic Pig Cardiac Xenograft.

    A. Singh,1 J. Chan,1 P. Corcoran,1 B. Lewis,2 M. Thomas,2 D. Ayares,3 K. Horvath,1 M. Mohiuddin.1

    1CSRP/NHLBI, NIH, Bethesda, MD; 2DVR/ORS, NIH, Bethesda, MD; 3Revivicor Inc., Blacksburg, VA.

    BackgroundXenotransplantation (XTx) involves the participation of innate immune system with natural antibody producing B cells, NK cells, macrophages and complement as well as adaptive immune…
  • 2016 American Transplant Congress

    Late Renal Xenograft Failure Is Antibody-Mediated: Description of the Longest-Reported Survival in Pig-to-Primate Renal Xenotransplantation.

    L. Higginbotham,1 S. Kim,1 D. Mathews,1 A. Stephenson,1 C. Breeden,1 C. Larsen,1 M. Ford,1 K. Newell,1 A. Tector,2 A. Adams.1

    1Emory Transplant Center, Emory University Hospital, Atlanta, GA; 2Indiana University School of Medicine, Indianapolis, IN.

    Introduction. Xenotransplantation has the potential to alleviate the organ supply shortage, yet pig-to-primate renal xenotransplant has met limited success due to natural preformed anti-pig antibody.…
  • 2016 American Transplant Congress

    Comparison of Early Engraftment Immunobiology of Xenoislets and Alloislets in a Dual Transplant Model.

    K. Samy,1 B. Martin,2 M. Song,1 B. Collins,1 E. Gall,1 J. Cano,2 A. Farris,2 F. Leopardi,1 A. Kirk.1,2

    1Department of Surgery, Duke University Medical Center, Durham, NC; 2Emory University, Atlanta, GA.

    Purpose: Successful implementation of neonatal porcine islet (NPI) xenotransplantation requires an understanding of the xenospecific immune elements influencing engraftment. To elucidate these early xenospecific processes,…
  • 2016 American Transplant Congress

    CXCL12 as Innovative Immune Isolating Chemokine for Microencapsulated Allo and Xeno-Transplantation in NHPs.

    M. Sremac,1 A. Saraya,1 O. Clemente,1 M. Penson,1 S. Chavan,3 N. Chronos,3 C. Schuetz,2 J. Lei,2 J. Markmann,2 T. Brauns,1 M. Poznansky.1

    1Infectious Disease/VIC, Massachusetts General Hospital, Boston, MA; 2Division of Transplantation, Massachusetts General Hospital, Boston, MA; 3VICapsys, Inc, Athens, GA.

    Introduction The purpose of this study is to determine whether a clinical-grade alginate-microencapsulant incorporating CXCL12, can protect and sustain the function of allo and/or adult…
  • 2016 American Transplant Congress

    Porcine Islets Engineered to Display SA-FasL Protein on Their Surface Induce Tolerance in Mice Following Transplantation into the Liver or Under the Kidney Capsule.

    H. Zhao,1 K. Woodward,1 H. Shirwan,1 M. Graham,2 B. Hering,2 E. Yolcu.1

    1Institute for Cellular Therapeutics and Department of Microbiology and Immunology, University of Louisville, Louisville, KY; 2Schulze Diabetes Institute and Department of Surgery, University of Minnesota, Minneapolis, MN.

    Introduction: We have recently demonstrated that allogeneic islets engineered to transiently display on their surface a novel form of FasL protein chimeric with streptavidin (SA-FasL)…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences